The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance
MW Mayo, AS Baldwin - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2000 - Elsevier
Discovered in 1986 as a DNA binding activity that recognized the immunoglobulin light
chain intronic enhancer, NF-κB has been studied intensively for its role in controlling …
chain intronic enhancer, NF-κB has been studied intensively for its role in controlling …
The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance
MW Mayo, AS Baldwin - Biochimica et biophysica acta, 2000 - pubmed.ncbi.nlm.nih.gov
Discovered in 1986 as a DNA binding activity that recognized the immunoglobulin light
chain intronic enhancer, NF-kappaB has been studied intensively for its role in controlling …
chain intronic enhancer, NF-kappaB has been studied intensively for its role in controlling …
[引用][C] The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance
MW Mayo, AS Baldwin - Biochimica et Biophysica Acta (BBA)-Reviews …, 2000 - cir.nii.ac.jp
The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance
MW Mayo, AS Baldwin - BBA-Reviews on Cancer, 2000 - infona.pl
Discovered in 1986 as a DNA binding activity that recognized the immunoglobulin light
chain intronic enhancer, NF-κB has been studied intensively for its role in controlling …
chain intronic enhancer, NF-κB has been studied intensively for its role in controlling …
The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance
MW Mayo, AS Baldwin - Biochimica et Biophysica Acta (BBA)/Reviews on …, 2000 - elibrary.ru
Discovered in 1986 as a DNA binding activity that recognized the immunoglobulin light
chain intronic enhancer, NF-κB has been studied intensively for its role in controlling …
chain intronic enhancer, NF-κB has been studied intensively for its role in controlling …
The transcription factor NF-κB: Control of oncogenesis and cancer therapy resistance
A Baldwin, MW Mayo - Biochimica et Biophysica Acta-Reviews on …, 2000 - cdr.lib.unc.edu
Discovered in 1986 as a DNA binding activity that recognized the immunoglobulin light
chain intronic enhancer, NF-kappaB has been studied intensively for its role in controlling …
chain intronic enhancer, NF-kappaB has been studied intensively for its role in controlling …
[PDF][PDF] The transcription factor NF-UB: control of oncogenesis and cancer therapy resistance
MW Mayo, AS Baldwin - core.ac.uk
Discovered in 1986 as a DNA binding activity that recognized the immunoglobulin light
chain intronic enhancer, NF-UB has been studied intensively for its role in controlling …
chain intronic enhancer, NF-UB has been studied intensively for its role in controlling …
The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance.
MW Mayo, AS Baldwin - Biochimica et Biophysica Acta, 2000 - europepmc.org
Discovered in 1986 as a DNA binding activity that recognized the immunoglobulin light
chain intronic enhancer, NF-kappaB has been studied intensively for its role in controlling …
chain intronic enhancer, NF-kappaB has been studied intensively for its role in controlling …
[引用][C] The transcription factor NF-kappa B: Control of oncogenesis and cancer therapy resisitance
MW MAYO - Biochim. Biophys. Acta., 2000 - cir.nii.ac.jp
The transcription factor NF-kappa B : Control of oncogenesis and cancer therapy resisitance |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …